These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 29566596)
21. The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancer. van de Velde ME; van den Berg MH; Kaspers GJL; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; van Litsenburg RRL Cancer Med; 2021 Nov; 10(22):8172-8181. PubMed ID: 34725942 [TBL] [Abstract][Full Text] [Related]
22. Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review. Smith EML; Kuisell C; Kanzawa-Lee GA; Bridges CM; Alberti P; Cavaletti G; Saad R; Park S; Lancet Haematol; 2020 May; 7(5):e408-e417. PubMed ID: 32359452 [TBL] [Abstract][Full Text] [Related]
23. Current methods for the assessment and management of taxane-related neuropathy. Smith EM Clin J Oncol Nurs; 2013 Feb; 17 Suppl():22-34. PubMed ID: 23360700 [TBL] [Abstract][Full Text] [Related]
24. Vincristine: Can its therapeutic index be enhanced? Moore A; Pinkerton R Pediatr Blood Cancer; 2009 Dec; 53(7):1180-7. PubMed ID: 19588521 [TBL] [Abstract][Full Text] [Related]
25. The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers. Gilchrist LS; Tanner L Support Care Cancer; 2013 Mar; 21(3):847-56. PubMed ID: 22993026 [TBL] [Abstract][Full Text] [Related]
26. Peripheral neuropathy in patients with gynecologic cancer receiving chemotherapy: patient reports and provider assessments. Kiser DW; Greer TB; Wilmoth MC; Dmochowski J; Naumann RW Oncol Nurs Forum; 2010 Nov; 37(6):758-64. PubMed ID: 21059587 [TBL] [Abstract][Full Text] [Related]
27. Obesity as a Potential Risk Factor for Vincristine-induced Peripheral Neuropathy. Sajdyk TJ; Boyle FA; Foran KS; Tong Y; Pandya P; Smith EML; Ho RH; Wells E; Renbarger JL J Pediatr Hematol Oncol; 2020 Oct; 42(7):e637-e640. PubMed ID: 31634238 [TBL] [Abstract][Full Text] [Related]
28. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia. Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029 [TBL] [Abstract][Full Text] [Related]
29. RISK FACTORS OF VINCRISTINE-INDUCED PERIPHERAL NEUROPATHY IN ACUTE LYMPHOBLASTIC LEUKAEMIA CHILDREN. Tunjungsari DA; Gunawan PI; Ugrasena IDG J Med Invest; 2021; 68(3.4):232-237. PubMed ID: 34759136 [TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study. Zgheib NK; Ghanem KM; Tamim H; Aridi C; Shahine R; Tarek N; Saab R; Abboud MR; El-Solh H; Muwakkit SA Pharmacogenet Genomics; 2018 Aug; 28(8):189-195. PubMed ID: 30119132 [TBL] [Abstract][Full Text] [Related]
31. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor. Schiavetti A; Frascarelli M; Uccini S; Novelli A Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281 [TBL] [Abstract][Full Text] [Related]
32. Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude Lifetime Cohort Study. Ness KK; Jones KE; Smith WA; Spunt SL; Wilson CL; Armstrong GT; Srivastava DK; Robison LL; Hudson MM; Gurney JG Arch Phys Med Rehabil; 2013 Aug; 94(8):1451-7. PubMed ID: 23537607 [TBL] [Abstract][Full Text] [Related]
33. Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis). Uittenboogaard A; van den Berg MH; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; Kaspers GJL; van de Velde ME Cancer Med; 2023 Oct; 12(19):19480-19490. PubMed ID: 37732486 [TBL] [Abstract][Full Text] [Related]
34. Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children. Gilchrist LS; Marais L; Tanner L Support Care Cancer; 2014 Feb; 22(2):359-66. PubMed ID: 24072474 [TBL] [Abstract][Full Text] [Related]
35. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia. Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123 [TBL] [Abstract][Full Text] [Related]
36. CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer. Skiles JL; Chiang C; Li CH; Martin S; Smith EL; Olbara G; Jones DR; Vik TA; Mostert S; Abbink F; Kaspers GJ; Li L; Njuguna F; Sajdyk TJ; Renbarger JL Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115708 [TBL] [Abstract][Full Text] [Related]
37. Short-term recovery of chemotherapy-induced peripheral neuropathy after treatment for pediatric non-CNS cancer. Gilchrist LS; Tanner LR; Ness KK Pediatr Blood Cancer; 2017 Jan; 64(1):180-187. PubMed ID: 27567009 [TBL] [Abstract][Full Text] [Related]
38. Acute motor and sensory axonal neuropathy in Burkitt-like lymphoma. Wanschitz J; Dichtl W; Budka H; Löscher WN; Boesch S Muscle Nerve; 2006 Oct; 34(4):494-8. PubMed ID: 16671108 [TBL] [Abstract][Full Text] [Related]
39. Experience with vincristine--associated neurotoxicity. Othieno-Abinya NA; Nyabola LO East Afr Med J; 2001 Jul; 78(7):376-8. PubMed ID: 11957264 [TBL] [Abstract][Full Text] [Related]
40. Glutamic acid not beneficial for the prevention of vincristine neurotoxicity in children with cancer. Bradfield SM; Sandler E; Geller T; Tamura RN; Krischer JP Pediatr Blood Cancer; 2015 Jun; 62(6):1004-10. PubMed ID: 25545757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]